1887

Abstract

A highly sensitive and rapid assay has been developed to quantify hepatitis B virus (HBV) DNA, based on the fluorescence resonance energy transfer principle and real-time PCR, using the LightCycler and a pair of specific fluorescent hybridization probes. This LightCycler real-time PCR assay (LC-PCR) detected HBV DNA in a linear range from 10 to 10 copies per reaction (250–2.5 × 10 copies ml), with a rapid PCR cycling time of 35 min. The assay was validated with two EUROHEP HBV DNA standards ( and subtypes) and exhibited low intra-assay (< 6 %) and inter-assay (< 16 %) variation for both subtypes over the complete range of 7 orders of magnitude. The assay was evaluated clinically using serum samples from 120 HBsAg individuals and 45 healthy controls who were negative for both HBsAg and anti-HBc. Levels of HBV DNA were measured in these samples using both the LC-PCR and Digene Hybrid Capture II HBV DNA (HCII) assays. The prevalence rates for HBV DNA in the HBsAg serum samples were respectively 95 % (114/120) and 56 % (67/120) by LC-PCR and HCII ( < 0.01). All 67 HCII-positive samples tested positive with LC-PCR, while the 47 discordant samples showed low levels of HBV DNA (down to 265 copies ml), detectable only by the more sensitive LC-PCR assay. Levels of HBV DNA as measured by the two assays showed good correlation ( = 0.902; < 0.001). The level of HBV DNA was significantly higher in HBeAg than anti-HBe samples (median 1.5 × 10 vs 4.6 × 10 copies ml; < 0.01). It is concluded that this LC-PCR assay is clinically useful for the rapid, sensitive and accurate measurement of HBV DNA.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.05071-0
2003-05-01
2019-11-18
Loading full text...

Full text loading...

/deliver/fulltext/jmm/52/5/JM520506.html?itemId=/content/journal/jmm/10.1099/jmm.0.05071-0&mimeType=html&fmt=ahah

References

  1. Abe, A., Inoue, K., Tanaka, T., Kato, J., Kajiyama, N., Kawaguchi, R., Tanaka, S., Yoshiba, M. & Kohara, M. ( 1999;). Quantitation of hepatitis B virus genomic DNA by real-time detection PCR. J Clin Microbiol 37, 2899–2903.
    [Google Scholar]
  2. Brechtbuehl, K., Whalley, S. A., Dusheiko, G. M. & Saunders, N. A. ( 2001;). A rapid real-time quantitative polymerase chain reaction for hepatitis B virus. J Virol Methods 93, 105–113.[CrossRef]
    [Google Scholar]
  3. Cane, P. A., Cook, P., Ratcliffe, D., Mutimer, D. & Pillay, D. ( 1999;). Use of real-time PCR and fluorimetry to detect lamivudine resistance- associated mutations in hepatitis B virus. Antimicrob Agents Chemother 43, 1600–1608.
    [Google Scholar]
  4. Chan, T. M., Wu, P. C., Li, F. K., Lai, C. L., Cheng, I. K. & Lai, K. N. ( 1998;). Treatment of fibrosing cholestatic hepatitis with lamivudine. Gastroenterology 115, 177–181.[CrossRef]
    [Google Scholar]
  5. Chan, T. M., Fang, G. X., Tang, C. S. O., Cheng, I. K. P., Lai, K. N. & Ho, S. K. N. ( 2002;). Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients. Hepatology 36, 1246–1252.[CrossRef]
    [Google Scholar]
  6. Chung, H. T., Lok, A. S. & Lai, C. L. ( 1993;). Re-evaluation of alpha-interferon treatment of chronic hepatitis B using polymerase chain reaction. J Hepatol 17, 208–214.[CrossRef]
    [Google Scholar]
  7. Espy, M. J., Uhl, J. R., Mitchell, P. S., Thorvilson, J. N., Svien, K. A., Wold, A. D. & Smith, T. F. ( 2000;). Diagnosis of herpes simplex virus infections in the clinical laboratory by LightCycler PCR. J Clin Microbiol 38, 795–799.
    [Google Scholar]
  8. Ghosh, S. S., Eis, P. S., Blumeyer, K., Fearon, K. & Millar, D. P. ( 1994;). Real time kinetics of restriction endonuclease cleavage monitored by fluorescence resonance energy transfer. Nucleic Acids Res 22, 3155–3159.[CrossRef]
    [Google Scholar]
  9. Heermann, K. H., Gerlich, W. H., Chudy, M., Schaefer, S. & Thomssen, R. ( 1999;). Quantitative detection of hepatitis B virus DNA in two international reference plasma preparations.Eurohep Pathobiology Group. J Clin Microbiol 37, 68–73.
    [Google Scholar]
  10. Hendricks, D. A., Stowe, B. J., Hoo, B. S., Kolberg, J., Irvine, B. D., Neuwald, P. D., Urdea, M. S. & Perrillo, R. P. ( 1995;). Quantitation of HBV DNA in human serum using a branched DNA (bDNA) signal amplification assay. Am J Clin Pathol 104, 537–546.
    [Google Scholar]
  11. Higuchi, R., Dollinger, G., Walsh, P. S. & Griffith, R. ( 1992;). Simultaneous amplification and detection of specific DNA sequences. Biotechnology 10, 413–417.[CrossRef]
    [Google Scholar]
  12. Ho, S. K. & Chan, T. M. ( 2000;). An overview of assays for serum HBV DNA. Clin Lab 46, 609–614.
    [Google Scholar]
  13. Ho, S. K., Chan, T. M., Cheng, I. K. & Lai, K. N. ( 1999;). Comparison of the second-generation digene hybrid capture assay with the branched-DNA assay for measurement of hepatitis B virus DNA in serum. J Clin Microbiol 37, 2461–2465.
    [Google Scholar]
  14. Holland, P. M., Abramson, R. D., Watson, R. & Gelfand, D. H. ( 1991;). Detection of specific polymerase chain reaction product by utilizing the 5′–3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci U S A 88, 7276–7280.[CrossRef]
    [Google Scholar]
  15. Jardi, R., Rodriguez, F., Buti, M., Costa, X., Cotrina, M., Valdes, A., Galimany, R., Esteban, R. & Guardia, J. ( 2001;). Quantitative detection of hepatitis B virus DNA in serum by a new rapid real-time fluorescence PCR assay. J Viral Hepat 8, 465–471.[CrossRef]
    [Google Scholar]
  16. Kaneko, S., Miller, R. H., Di Bisceglie, A. M., Feinstone, S. M., Hoofnagle, J. H. & Purcell, R. H. ( 1990;). Detection of hepatitis B virus DNA in serum by polymerase chain reaction.Application for clinical diagnosis. Gastroenterology 99, 799–804.
    [Google Scholar]
  17. Kessler, H. H., Pierer, K., Dragon, E., Lackner, H., Santner, B., Stunzner, D., Stelzl, E., Waitzl, B. & Marth, E. ( 1998;). Evaluation of a new assay for HBV DNA quantitation in patients with chronic hepatitis B. Clin Diagn Virol 9, 37–43.[CrossRef]
    [Google Scholar]
  18. Lai, C. L., Chien, R. N., Leung, N. W. & 9 other authors ( 1998;). A one-year trial of lamivudine for chronic hepatitis B.Asia Hepatitis Lamivudine Study Group. N Engl J Med 339, 61–68.[CrossRef]
    [Google Scholar]
  19. Lai, V. C., Guan, R., Wood, M. L., Lo, S. K., Yuen, M. F. & Lai, C. L. ( 1999;). Nucleic acid-based cross-linking assay for detection and quantification of hepatitis B virus DNA. J Clin Microbiol 37, 161–164.
    [Google Scholar]
  20. Lee, W. M. ( 1997;). Hepatitis B virus infection. N Engl J Med 337, 1733–1745.[CrossRef]
    [Google Scholar]
  21. Loeb, K. R., Jerome, K. R., Goddard, J., Huang, M., Cent, A. & Corey, L. ( 2000;). High-throughput quantitative analysis of hepatitis B virus DNA in serum using the TaqMan fluorogenic detection system. Hepatology 32, 626–629.[CrossRef]
    [Google Scholar]
  22. Niesters, H. G., Krajden, M., Cork, L., de Medina, M., Hill, M., Fries, E. & Osterhaus, A. D. ( 2000;). A multicenter study evaluation of the digene hybrid capture II signal amplification technique for detection of hepatitis B virus DNA in serum samples and testing of EUROHEP standards. J Clin Microbiol 38, 2150–2155.
    [Google Scholar]
  23. Noborg, U., Gusdal, A., Pisa, E. K., Hedrum, A. & Lindh, M. ( 1999;). Automated quantitative analysis of hepatitis B virus DNA by using the Cobas Amplicor HBV monitor test. J Clin Microbiol 37, 2793–2797.
    [Google Scholar]
  24. Omata, M. ( 1998;). Treatment of chronic hepatitis B infection. N Engl J Med 339, 114–115.[CrossRef]
    [Google Scholar]
  25. Paraskevis, D., Haida, C., Tassopoulos, N., Raptopoulou, M., Tsantoulas, D., Papachristou, H., Sypsa, V. & Hatzakis, A. ( 2002;). Development and assessment of a novel real-time PCR assay for quantitation of HBV DNA. J Virol Methods 103, 201–212.[CrossRef]
    [Google Scholar]
  26. Pas, S. D., Fries, E., De Man, R. A., Osterhaus, A. D. & Niesters, H. G. ( 2000;). Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays. J Clin Microbiol 38, 2897–2901.
    [Google Scholar]
  27. Puchhammer-Stockl, E., Mandl, C. W., Kletzmayr, J., Holzmann, H., Hofmann, A., Aberle, S. W., Heinz, F. X., Watschinger, B. & Hofmann, H. ( 2000;). Monitoring the virus load can predict the emergence of drug-resistant hepatitis B virus strains in renal transplantation patients during lamivudine therapy. J Infect Dis 181, 2063–2066.[CrossRef]
    [Google Scholar]
  28. Quint, W. G., Heijtink, R. A., Schirm, J., Gerlich, W. H. & Niesters, H. G. ( 1995;). Reliability of methods for hepatitis B virus DNA detection. J Clin Microbiol 33, 225–228.
    [Google Scholar]
  29. Weinberger, K. M., Wiedenmann, E., Bohm, S. & Jilg, W. ( 2000;). Sensitive and accurate quantitation of hepatitis B virus DNA using a kinetic fluorescence detection system (TaqMan PCR). J Virol Methods 85, 75–82.[CrossRef]
    [Google Scholar]
  30. Whalley, S. A., Brown, D., Teo, C. G., Dusheiko, G. M. & Saunders, N. A. ( 2001;). Monitoring the emergence of hepatitis B virus polymerase gene variants during lamivudine therapy using the LightCycler. J Clin Microbiol 39, 1456–1459.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.05071-0
Loading
/content/journal/jmm/10.1099/jmm.0.05071-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error